The association of the paraoxonase 1 Q192R polymorphism with coronary artery disease (CAD) and cardiometabolic risk factors in Iranian patients suspected of CAD

被引:3
|
作者
Darand, Mina [1 ]
Salehi-Abargouei, Amin [2 ,3 ,4 ]
Vahidi Mehrjardi, Mohammad Yahya [5 ]
Feizi, Awat [6 ]
Seyedhossaini, Seyed Mustafa [4 ]
Askari, Gholamreza [1 ]
机构
[1] Isfahan Univ Med Sci, Nutr & Food Secur Res Ctr, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran
[2] Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran
[3] Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Dept Nutr, Yazd, Iran
[4] Shahid Sadoughi Univ Med Sci, Noncommunicable Dis Res Inst, Yazd Cardiovasc Res Ctr, Yazd, Iran
[5] Shahid Sadoughi Univ Med Sci, Res Ctr Food Hyg & Safety, Sch Publ Hlth, Yazd, Iran
[6] Isfahan Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Esfahan, Iran
来源
关键词
PON1; Q192R polymorphism; rs662; lipid profile; coronary artery disease; LOW-DENSITY-LIPOPROTEIN; PON1; GENE; LIPID-METABOLISM; TURKISH PATIENTS; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; CHOLESTEROL; SEVERITY; ADULTS;
D O I
10.3389/fcvm.2022.1037940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe present study aimed to investigate the association of the paraoxonase 1 (PON1) Q192R polymorphism with coronary artery disease (CAD) and cardiometabolic risk factors in Iranian patients suspected of CAD. MethodsThis cross-sectional study was conducted on 428 patients undergoing angiography. The data related to demographic information and physical activity were collected by valid and reliable questionnaires. The PON-1 genotypes were detected by the polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR) technique. The Gensini and SYNTAX score, anthropometric measurements, and biochemical and clinical parameters were measured by standard protocols. Results and discussionFindings indicated that the odds of obesity was significantly higher in people with the RR genotype compared to the QQ genotype carriers (OR: 2.95 CI: 1.25-6.93, P = 0.014) and also odds of low high-density lipoprotein cholesterol (HDL-C) was marginally higher (OR: 2.31 CI: 0.97-5.49, P = 0.056). There was no significant association between other CAD risk factors with PON1 Q192R polymorphism (P > 0.05). Further analysis showed a significant interaction between sex and 192QR (P = 0.019) and 192 RR (P = 0.007) genotypes on body mass index (BMI). More specifically, the risk of obesity in men carrying the RR genotype was 3.38 times (OR: 3.38 CI: 1.08-10.58, P = 0.036). Also, a significant joint effect of the RR genotype and sex on HDL-C was seen (P = 0.003). The stratification based on sex showed that the risk of low HDL-C is significantly higher in women carrying the RR genotype (OR: 6.18 CI: 1.21-31.46, P = 0.028). A marginal sex-genotype interaction was also found in the risk of elevated alanine aminotransferase (ALT) (P = 0.057). In summary, the findings showed that the risk of obesity and low HDL-C was higher in people carrying the RR genotype. On the other hand, a Q192R polymorphism-sex interaction was observed on the risk of obesity, elevated ALT, and low HDL-C.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
    Trenk, Dietmar
    Hochholzer, Willibald
    Fromm, Martin F.
    Zolk, Oliver
    Valina, Christian M.
    Stratz, Christian
    Neumann, Franz-Josef
    CIRCULATION-CARDIOVASCULAR GENETICS, 2011, 4 (04) : 429 - 436
  • [22] The human paraoxonase Gln-Arg192 (Q/R) polymorphism in Turkish patients with coronary artery disease
    Aynacioglu, AS
    Kepekci, Y
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 74 (01) : 33 - 37
  • [23] Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients
    Yang Jie
    Zhou Jun-Shan
    Tan Jie
    He Bang-Shun
    Zou Jian-Jun
    PHARMAZIE, 2012, 67 (12): : 1026 - 1029
  • [24] Cholinesterases activity and paraoxonase 1 Q192R polymorphism of workers exposed to pesticides
    Molina-Pintor, I. B.
    Bernal-Hernandez, Y. Y.
    Rojas-Garcia, A. E.
    Medina-Diaz, I. M.
    Herrera Moreno, J. F.
    Alvarez Puentes, G. A.
    Barron-Vivanco, B. S.
    TOXICOLOGY LETTERS, 2016, 259 : S210 - S210
  • [25] Polymorphism rs662 (Q192R) of paraoxonase-1 and susceptibility to atherosclerosis of the coronary arteries
    Baranska, Malgorzata
    Rychlik-Sych, Mariola
    Dudarewicz, Michal
    Wiktorowska-Owczarek, Anna
    Owczarek, Jacek
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (04) : 1328 - 1333
  • [26] Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement
    Trenk, D.
    Hochholzer, W.
    Fromm, M. F.
    Zolk, O.
    Valina, C. M.
    Stratz, C.
    Neumann, F-J.
    EUROPEAN HEART JOURNAL, 2011, 32 : 508 - 508
  • [27] Paraoxonase-1 Gene Q192R Polymorphism and Reactive Oxygen Metabolites
    Kotani, K.
    Tsuzaki, K.
    Sakane, N.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (04) : 1513 - 1518
  • [28] Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran
    Hashemi, M.
    Moazeni-Roodi, A. K.
    Fazaeli, A.
    Sandoughi, M.
    Bardestani, G. R.
    Kordi-Tamandani, D. M.
    Ghavami, S.
    GENETICS AND MOLECULAR RESEARCH, 2010, 9 (01): : 333 - 339
  • [29] Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population
    Corredor-Orlandelli, David
    Sambracos-Parrado, Santiago
    Mantilla-Garcia, Santiago
    Tovar-Tirado, Josue
    Vega-Ramirez, Valentina
    Mendoza-Ayus, Santiago David
    Pena, Laura Catalina
    Leal, Maria Fernanda
    Rodriguez-Carrillo, Juliana
    Leon-Torres, Juanita
    Pardo-Oviedo, Juan Mauricio
    Abaunza, Katherine Parra
    Bravo, Nora Contreras Contreras
    Ortega-Recalde, Oscar
    Mendoza, Dora Janeth Fonseca
    VASCULAR HEALTH AND RISK MANAGEMENT, 2021, 17 : 689 - 699
  • [30] Paraoxonase 1 gene (Q192R) polymorphism confers susceptibility to coronary artery disease in type 2 diabetes patients: Evidence from case-control studies
    Huo, Xiaowei
    Guo, Yuan
    Zhang, Yongjian
    Li, Jieqiong
    Wen, Xiulin
    Liu, Jinjin
    DRUG DISCOVERIES AND THERAPEUTICS, 2019, 13 (02): : 80 - 88